Evidence map›Paper›PMID 31235265›Full record

ArticleBioorganic & medicinal chemistry2019

Advances in the structural studies of antibiotic potentiators against Escherichia coli.

Gifty A Blankson, Ajit K Parhi, Malvika Kaul, Daniel S Pilch, Edmond J LaVoie

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Broadly Defined Antibiotic Adjuvants forThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gifty A BlanksonDepartment of Medicinal Chemistry, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA.
Ajit K ParhiDepartment of Medicinal Chemistry, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA; TAXIS Pharmaceuticals, Inc., Monmouth Junction, NJ 08552, USA.
Malvika KaulDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854-5635, USA.
Daniel S PilchDepartment of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854-5635, USA. Electronic address: pilchds@rwjms.rutgers.edu.
Edmond J LaVoieDepartment of Medicinal Chemistry, Rutgers, The State University of New Jersey, Piscataway, NJ 08854-8020, USA. Electronic address: elavoie@pharmacy.rutgers.edu.

Funding

Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureusR01AI118874 · NIAID · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI PILCH, DANIEL S · 2016 to 2020
$2.0M
NIAID NIH HHS R01 AI118874
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmidesAnti-Bacterial AgentsDose-Response Relationship, DrugEscherichia coliMicrobial Sensitivity TestsMolecular StructureStructure-Activity RelationshipAmidesAnti-Bacterial Agents

Identifiers

PMID31235265
PMCPMC6650317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.